AIM ImmunoTech Inc. (AIM)
NYSEAMERICAN: AIM · IEX Real-Time Price · USD
0.378
+0.008 (2.08%)
Jul 22, 2024, 12:14 PM EDT - Market open
AIM ImmunoTech Employees
As of December 31, 2023, AIM ImmunoTech had 28 total employees, including 26 full-time and 2 part-time employees. The number of employees increased by 4 or 16.67% compared to the previous year.
Employees
28
Change (1Y)
4
Growth (1Y)
16.67%
Revenue / Employee
$6,893
Profits / Employee
-$1,111,357
Market Cap
21.71M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Cosmos Health | 102 |
Cumberland Pharmaceuticals | 91 |
Jaguar Health | 49 |
Viracta Therapeutics | 40 |
Oncternal Therapeutics | 30 |
OneMedNet | 20 |
TRxADE HEALTH | 8 |
AIM News
- 19 days ago - AIM ImmunoTech Announces Release of the Next CEO Corner Segment - GlobeNewsWire
- 6 weeks ago - AIM ImmunoTech to Participate in the Virtual Investor Pitch Conference - GlobeNewsWire
- 7 weeks ago - AIM ImmunoTech to Participate in the Virtual Investor Lunch Break Series - GlobeNewsWire
- 7 weeks ago - AIM ImmunoTech Announces Pricing of $2.0 Million Registered Direct Offering - GlobeNewsWire
- 2 months ago - AIM ImmunoTech to Participate in Two Upcoming Investor Conferences - GlobeNewsWire
- 2 months ago - AIM ImmunoTech Reports First Quarter 2024 Financial Results and Provides Corporate Update - GlobeNewsWire
- 2 months ago - AIM ImmunoTech to Discuss First Quarter 2024 Financial Results on May 16, 2024, and Host Conference Call and Webcast - GlobeNewsWire
- 2 months ago - AIM ImmunoTech Completes cGMP Manufacturing of Clinical Vials of Ampligen® - GlobeNewsWire